Notebook

Twenty-five years after the notorious Tuskegee study came to light, the United States government will formally apologize to its unwitting participants. The White House announced in early April that President Clinton soon would issue an apology to the 399 African American men whose syphilis was observed from 1932 to 1972 as part of an experiment by the U.S. Public Health Service. Despite the discovery in 1947 that penicillin cures syphilis, researchers neither treated the men nor told them they


Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Twenty-five years after the notorious Tuskegee study came to light, the United States government will formally apologize to its unwitting participants. The White House announced in early April that President Clinton soon would issue an apology to the 399 African American men whose syphilis was observed from 1932 to 1972 as part of an experiment by the U.S. Public Health Service. Despite the discovery in 1947 that penicillin cures syphilis, researchers neither treated the men nor told them they had the disease. The study is often cited as a primary reason for minority people's mistrust of science and scientists (T.W. Durso, The Scientist, Feb. 17, 1997, page 1), and observers feel an apology should help rebuild trust. "For the president to say that this has been an affront against part of the human race is really important qualitatively, because it makes a threshold after which nobody can deny that this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide